DESIREE LILLEY: Open Payments
NPI 1790550408 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,094 in 125 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $2,045 · 2025 $2,094
Food & beverage: $2,094
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $262 |
| PFIZER INC. | 18 | $243 |
| ABBVIE INC. | 16 | $215 |
| Amgen Inc. | 14 | $163 |
| Lilly USA, LLC | 7 | $145 |
| GlaxoSmithKline, LLC. | 7 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| Novartis Pharmaceuticals Corporation | 6 | $112 |
| Novo Nordisk Inc | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
Products named: ELIQUIS, REXULTI, TRELEGY ELLIPTA, NURTEC ODT, LEQVIO, Sunosi, Auvelity, OTEZLA.
Industry payments across VA — which companies pay providers there.
